An antipsychotic approved by the FDA in 2009 to treat schizophrenia has now been green-lighted for use in bipolar 1 disorder. Iloperidone (Fanapt) is now FDA-approved for adults with bipolar 1 ...
Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder. Iloperidone is a second-generation atypical antipsychotic agent for managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results